• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(乳酸-共-乙醇酸)纳米粒的聚乙二醇化程度对增强洛哌丁胺中枢神经系统递送的比较评价。

Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.

机构信息

School of Pharmacy, Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Pharmacology, PU-RCSI School of Medicine, Perdana University, Selangor, Malaysia.

出版信息

J Pharm Pharmacol. 2013 Oct;65(10):1473-81. doi: 10.1111/jphp.12125. Epub 2013 Aug 1.

DOI:10.1111/jphp.12125
PMID:24028614
Abstract

OBJECTIVES

In this study, we examined the relative cellular uptake of nanoparticles (NPs) formulated using poly(lactic-co-glycolic acid) (PLGA) polymers with increasing degree of pegylation (PLGA-PEG) and their potential to deliver loperamide to the brain of a mouse.

METHOD

NPs containing coumarin-6 or loperamide HCl were formulated using PLGA and PLGA-PEG, with PEG content of 5-15%, by the solvent evaporation method. NPs were characterised for size, surface charge, morphology, encapsulation efficiency and drug release. Cellular uptake of coumarin-6 NPs was examined in Caco-2 monolayers using confocal microscopy and central nervous system (CNS) delivery of loperamide HCl from the NPs was examined following intranasal administration in a mouse model.

KEY FINDINGS

No difference in NP characteristics was observed, irrespective of degree of pegylation, except for the surface charge which increased with increasing PEG content. PLGA-PEG NPs were found to have increased cellular uptake in comparison to PLGA NPs. Interestingly, this pattern was reflected in the CNS delivery of loperamide HCl in the mouse model.

CONCLUSION

The results from this study show that PLGA-PEG NPs have the potential to act as carriers for the noninvasive administration of therapeutic agents to the brain and possibly across other physiological barriers.

摘要

目的

在这项研究中,我们研究了使用聚(乳酸-共-乙醇酸)(PLGA)聚合物与不同程度的聚乙二醇化(PLGA-PEG)制备的纳米颗粒(NPs)的相对细胞摄取及其将洛哌丁胺递送至小鼠大脑的潜力。

方法

通过溶剂蒸发法,使用 PLGA 和 PLGA-PEG(PEG 含量为 5-15%)制备了含有香豆素-6 或盐酸洛哌丁胺的 NPs。对 NPs 的大小、表面电荷、形态、包封效率和药物释放进行了表征。通过共聚焦显微镜研究了 Caco-2 单层中香豆素-6 NPs 的细胞摄取,并在小鼠模型中通过鼻内给药研究了 NPs 中盐酸洛哌丁胺对中枢神经系统(CNS)的递送。

主要发现

除了表面电荷随 PEG 含量增加而增加外,无论 PEG 化程度如何,NPs 的特性均无差异。与 PLGA NPs 相比,PLGA-PEG NPs 的细胞摄取量增加。有趣的是,这种模式反映在小鼠模型中盐酸洛哌丁胺对 CNS 的递送中。

结论

本研究结果表明,PLGA-PEG NPs 有可能作为非侵入性给药载体,将治疗剂递送至大脑,并可能递送至其他生理屏障。

相似文献

1
Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.聚(乳酸-共-乙醇酸)纳米粒的聚乙二醇化程度对增强洛哌丁胺中枢神经系统递送的比较评价。
J Pharm Pharmacol. 2013 Oct;65(10):1473-81. doi: 10.1111/jphp.12125. Epub 2013 Aug 1.
2
Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.八聚精氨酸修饰的聚乳酸-乙醇酸共聚物纳米颗粒经鼻内和静脉给药可促进洛哌丁胺向中枢神经系统的递送。
J Pharm Pharmacol. 2015 Apr;67(4):525-36. doi: 10.1111/jphp.12347. Epub 2014 Dec 17.
3
Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.PLGA-PEG-PLGA 纳米粒表面修饰对洛哌丁胺透过血脑屏障递送效率的影响。
J Biomater Appl. 2013 Mar;27(7):909-22. doi: 10.1177/0885328211429495. Epub 2011 Dec 29.
4
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.用于多西他赛口服递送的聚丙交酯-维生素E衍生物/蒙脱石纳米颗粒制剂
Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.
5
Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.超细微粒聚乙二醇包覆的聚乳酸-共-羟基乙酸通过疏水性表面活性剂辅助的一锅合成法制备,用于生物医学应用。
Nanotechnology. 2011 May 6;22(18):185601. doi: 10.1088/0957-4484/22/18/185601. Epub 2011 Mar 17.
6
Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.聚天冬氨酸肽连接的基于聚乳酸-羟基乙酸共聚物的纳米颗粒:骨靶向药物递送应用的潜力。
Int J Pharm. 2014 Nov 20;475(1-2):547-57. doi: 10.1016/j.ijpharm.2014.08.067. Epub 2014 Sep 4.
7
Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer.载硫酸长春新碱的叶酸修饰聚乳酸-羟基乙酸共聚物-聚乙二醇纳米粒增强人乳腺癌细胞摄取
Drug Dev Ind Pharm. 2011 Nov;37(11):1339-46. doi: 10.3109/03639045.2011.575162. Epub 2011 Apr 27.
8
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.唾液酸和糖肽偶联的 PLGA 纳米粒用于中枢神经系统靶向:体内药代动力学证据和生物分布。
J Control Release. 2010 Jul 1;145(1):49-57. doi: 10.1016/j.jconrel.2010.03.008. Epub 2010 Mar 23.
9
Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.经颈动脉给药的表面修饰聚(D,L-乳酸-共-乙醇酸)纳米粒脑靶向给药。
Eur J Pharm Biopharm. 2011 Jan;77(1):84-8. doi: 10.1016/j.ejpb.2010.11.002. Epub 2010 Nov 11.
10
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.具有脂质单分子层壳和可生物降解聚合物核的纳米颗粒用于紫杉醇的控制释放:表面活性剂对颗粒大小、特性和体外性能的影响。
Int J Pharm. 2010 Aug 16;395(1-2):243-50. doi: 10.1016/j.ijpharm.2010.05.008. Epub 2010 May 20.

引用本文的文献

1
Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines.基于聚乳酸-羟基乙酸共聚物的纳米药物表面功能化的最新进展
Nanomaterials (Basel). 2022 Jan 22;12(3):354. doi: 10.3390/nano12030354.
2
Drug delivery of 6-bromoindirubin-3'-glycerol-oxime ether employing poly(D,L-lactide-co-glycolide)-based nanoencapsulation techniques with sustainable solvents.采用聚(D,L-丙交酯-共-乙交酯)-基于纳米胶囊化技术的可持续溶剂药物递送 6-溴靛红-3'-甘油-肟醚。
J Nanobiotechnology. 2022 Jan 4;20(1):5. doi: 10.1186/s12951-021-01179-7.
3
Optimising PLGA-PEG Nanoparticle Size and Distribution for Enhanced Drug Targeting to the Inflamed Intestinal Barrier.
优化聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒的大小和分布以增强药物对炎症性肠屏障的靶向作用。
Pharmaceutics. 2020 Nov 19;12(11):1114. doi: 10.3390/pharmaceutics12111114.
4
Effect of Size and Concentration of PLGA-PEG Nanoparticles on Activation and Aggregation of Washed Human Platelets.聚乳酸-羟基乙酸共聚物-聚乙二醇纳米颗粒的尺寸和浓度对洗涤后人体血小板活化和聚集的影响
Pharmaceutics. 2019 Oct 4;11(10):514. doi: 10.3390/pharmaceutics11100514.
5
Single-Emulsion P(HB-HV) Microsphere Preparation Tuned by Copolymer Molar Mass and Additive Interaction.通过共聚物摩尔质量和添加剂相互作用调控的单乳液聚(羟基丁酸-羟基戊酸)微球制备
ACS Omega. 2019 May 3;4(5):8122-8135. doi: 10.1021/acsomega.9b00824. eCollection 2019 May 31.
6
Epilepsy Disease and Nose-to-Brain Delivery of Polymeric Nanoparticles: An Overview.癫痫疾病与聚合物纳米颗粒的鼻脑递送:概述
Pharmaceutics. 2019 Mar 13;11(3):118. doi: 10.3390/pharmaceutics11030118.
7
Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.纳米颗粒与血脑屏障:从体外模型迈向治疗意义
Pharm Res. 2015 Apr;32(4):1161-85. doi: 10.1007/s11095-014-1545-6. Epub 2014 Dec 2.